封面
市场调查报告书
商品编码
1533983

血管栓塞装置的全球市场

Vascular Embolization Devices

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 250 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球血管栓塞器材市场将达26亿美元

2023年全球血管栓塞器械市场估计为19亿美元,预计到2030年将达到26亿美元,2023年至2030年复合年增长率为4.7%。捲取设备是本报告分析的细分市场之一,预计复合年增长率为 4.2%,到分析期结束时将达到 16 亿美元。分析期间内,非捲取设备领域的复合年增长率预计为 5.5%。

美国市场预估为5.075亿美元,中国预期复合年增长率为7.6%

预计 2023 年美国血管栓塞器械市场规模将达到 5.075 亿美元。中国作为世界第二大经济体,预计2030年市场规模将达5.233亿美元,2023-2030年分析期间复合年增长率为7.6%。其他值得注意的区域市场包括日本和加拿大,在分析期间预计复合年增长率分别为 1.8% 和 4.8%。在欧洲,德国的复合年增长率预计为 2.8%。

全球血管栓塞器械市场-主要驱动因素与趋势总结

栓塞装置是一种用于有意阻止血管内血流的医疗装置。此手术对于治疗多种疾病至关重要,包括出血、动脉瘤、动静脉畸形和某些癌症。这些装置由线圈、颗粒、塞子或液体栓塞剂组成,并透过导管输送到目标部位。阻断血流可以透过减少出血、缩小血管畸形的大小以及切断肿瘤的血液供应来防止肿瘤生长或转移。血管栓塞是一种微创治疗方法,是传统手术方法的安全治疗方法。

由于装置技术和材料的不断改进,血管栓塞领域多年来取得了长足的进展。现代血管栓塞装置的设计旨在提高精度和有效性,并且通常采用生物可吸收材料,这些材料在达到目的后会溶解,从而降低长期併发症的风险。可拆卸弹簧圈和先进液体栓塞剂的发展彻底改变了复杂血管病变的治疗。即时透视和 MRI 导引栓塞等诊断影像技术的进步提高了这些手术的精确度,从而实现更好的治疗效果和更短的恢復时间。此外,这些设备的应用范围正在从紧急干预扩展到治疗子宫肌瘤和静脉曲张等慢性疾病的选择性手术。

血管栓塞设备市场的成长受到多种因素的推动。首先,动脉瘤和动静脉畸形等血管疾病的盛行率不断增加,增加了对有效治疗方案的需求。其次,世界人口老化使其更容易受到这种情况的影响,进一步推动了市场的成长。基于导管的输送系统和栓塞材料的技术进步扩大了可治疗疾病的范围并改善了患者的治疗结果。增加医疗基础设施和获得先进医疗技术,尤其是在新兴市场,也在市场扩张中发挥重要作用。此外,医疗设备製造商和研究机构之间的策略联盟正在加速创新和新产品开发。最后,医疗保健专业人员和患者对微创手术益处的认识不断提高,正在推动栓塞设备的采用并巩固其在现代医学中的作用。

受访企业范例(共86家)

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Embolx, Inc.
  • Kaneka Corporation
  • Lepu Medical Technology(Beijing)Co., Ltd.
  • Medtronic
  • Merit Medical Systems, Inc.
  • NeuroSafe Medical Co., Ltd
  • Penumbra, Inc
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Medical Corporation
  • Wallaby Medical, LLC.
  • Zylox-Tonbridge Medical Technology Co. Ltd.;

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP26612

Global Vascular Embolization Devices Market to Reach US$2.6 Billion by 2030

The global market for Vascular Embolization Devices estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Coiling Devices, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Non-Coiling Devices segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$507.5 Million While China is Forecast to Grow at 7.6% CAGR

The Vascular Embolization Devices market in the U.S. is estimated at US$507.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$523.3 Million by the year 2030 trailing a CAGR of 7.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Vascular Embolization Devices Market - Key Drivers and Trends Summarized

Vascular embolization devices are medical instruments used to obstruct blood flow within a vessel deliberately. This procedure is critical in treating various conditions, including hemorrhages, aneurysms, arteriovenous malformations, and certain cancers. These devices can consist of coils, particles, plugs, or liquid embolic agents, which are delivered via catheters to the target area. By blocking the blood flow, these devices help to control bleeding, reduce the size of vascular malformations, or cut off blood supply to tumors, thus preventing their growth and spread. Vascular embolization is a minimally invasive procedure, offering a safer alternative to traditional surgical methods.

The field of vascular embolization has seen significant advancements over the years, with continuous improvements in device technology and materials. Modern embolization devices are designed for higher precision and efficacy, often incorporating bioresorbable materials that dissolve after fulfilling their purpose, reducing the risk of long-term complications. The development of detachable coils and advanced liquid embolic agents has revolutionized the treatment of complex vascular conditions. Imaging advancements, such as real-time fluoroscopy and MRI-guided embolization, have enhanced the accuracy of these procedures, allowing for better outcomes and shorter recovery times. Additionally, the application of these devices has expanded beyond emergency interventions to include elective procedures for managing chronic conditions like uterine fibroids and varicose veins.

The growth in the vascular embolization devices market is driven by several factors. Firstly, the increasing prevalence of vascular diseases, such as aneurysms and arteriovenous malformations, has led to a higher demand for effective treatment options. Secondly, the aging global population, which is more prone to such conditions, further fuels market growth. Technological advancements in catheter-based delivery systems and embolic materials have broadened the range of treatable conditions and improved patient outcomes. The rise in healthcare infrastructure and access to advanced medical technologies, particularly in emerging markets, has also played a crucial role in market expansion. Additionally, strategic collaborations between medical device manufacturers and research institutions are accelerating innovation and the development of new products. Finally, increased awareness among healthcare professionals and patients about the benefits of minimally invasive procedures has driven the adoption of embolization devices, solidifying their role in modern medical practice.

Select Competitors (Total 86 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Embolx, Inc.
  • Kaneka Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic
  • Merit Medical Systems, Inc.
  • NeuroSafe Medical Co., Ltd
  • Penumbra, Inc
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Medical Corporation
  • Wallaby Medical, LLC.
  • Zylox-Tonbridge Medical Technology Co. Ltd.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Vascular Embolization Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Vascular Diseases Propels Demand for Embolization Devices
    • Technological Advancements in Embolization Techniques Enhance Treatment Efficacy
    • Growing Preference for Minimally Invasive Procedures Drives Market Growth
    • Expanding Applications of Embolization Devices in Oncology Spurs Market Expansion
    • Development of Bioabsorbable Embolization Materials Generates Market Interest
    • Integration of AI and Robotics in Vascular Procedures Drives Market Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vascular Embolization Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vascular Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vascular Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Vascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Coiling Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Coiling Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Coiling Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-Coiling Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Non-Coiling Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Non-Coiling Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Neurology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Peripheral Vascular Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Peripheral Vascular Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Peripheral Vascular Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Vascular Embolization Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Vascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Vascular Embolization Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Vascular Embolization Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Vascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Vascular Embolization Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Vascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION